Assystem
Miriam Maes is Independent Director & Chair of the Compensation Committee at Assystem. Prior to this, they were with ERAMET and URENCO Group. From December 2013 to December 2019, they were with LIMAGRAIN as the Non-Executive Director on the Board and Chairman of the Audit Committee. There, they were in charge of the listed activity Vilmorin & Cie and was responsible for the overall management of the company. Prior to LIMAGRAIN, Ms. Maes was with Sabien Technology Limited from November 2012 to November 2015 as the Chairman of Sabien Technology Group. There, they were responsible for providing proven and commercially viable technology to reduce carbon emissions and energy usage for private and public organisations. Before Sabien Technology Limited, Ms. Maes was the Founder and Chairman of Energy Transition Forum 2.0 from ENERGY TRANSITION FORUM LIMITED. Lastly, they were a Non-Resident Climate and Energy Program Fellow from May 2012 to December 2014 with German Marshall Fund of the United States.
This person is not in the org chart
This person is not in any offices
Assystem
3 followers
Assystem SA is a France-based company that is principally engaged in engineering and innovation consultancy. The Company offers solutions within a number of sectors, such as Aerospace, Defence, Energy, Nuclear, Life Sciences, Infrastructure, Automotive and Transport. The Company develops the infrastructural engineering and externalized R&D services. It's activities include managing infrastructural investments, from conception to dismantling; aerospace mechanical engineering, providing technical services to aerospace, engine and automotive manufacturers and technology & product engineering, providing services in transport, defense, product hardware and software development. The Company is present Europe, North America and Asia. The main shareholder of the Company is HDL Developpement SAS. It operates through Onyx Promavi, Batir Group, Edison Technical Recruitment Ltd, Radicon Gulf Consult, Engineering Partner Automotive Nordic AB and The Biotech Quality Group, among others.